{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:48:15Z","timestamp":1792586895068,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA234281"],"award-info":[{"award-number":["R01CA234281"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["5P30CA044579-27"],"award-info":[{"award-number":["5P30CA044579-27"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijrobp.2026.07.012","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:07:16Z","timestamp":1784732836000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["First Measurement: Proactively Sparing the Immune System During Stereotactic Body Radiation Therapy to Early-Stage Lung Cancer\u2014A Randomized Phase II Study"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4283-1609","authenticated-orcid":false,"given":"Krishni","family":"Wijesooriya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cam","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R","family":"Conaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence G.","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Lain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K.","family":"Luminais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryant","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damon","family":"Sprouts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cousins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebenezer","family":"Asare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Nesbit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yhana C.","family":"Chavis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin V.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einsley","family":"Janowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Showalter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Larner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.07.012_bib0001","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nature06309","article-title":"Adaptive immunity maintains occult cancer in an equilibrium state","volume":"450","author":"Koebel","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0002","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0003","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2172-11-19","article-title":"Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients","volume":"11","author":"Deschoolmeester","year":"2010","journal-title":"BMC Immunol"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0004","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/onc.2009.416","article-title":"Immune infiltration in human tumors: A prognostic factor that should not be ignored","volume":"29","author":"Pag\u00e8s","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0005","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/cncr.23712","article-title":"Predominant infiltration of macrophages and CD8+T Cells in cancer nests is a significant predictor of survival in stage IV non small cell lung cancer","volume":"113","author":"Kawai","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0006","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2007.15.0284","article-title":"Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures","volume":"26","author":"Dieu-Nosjean","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0007","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1158\/2326-6066.CIR-13-0141","article-title":"Harnessing the potential of radiation-induced immune modulation for cancer therapy","volume":"1","author":"Ahmed","year":"2013","journal-title":"Cancer Immunol Res."},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0008","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/gut.43.4.575","article-title":"Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis","volume":"43","author":"Ohba","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0009","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1172\/JCI117045","article-title":"Transforming growth factor-beta activation in irradiated murine mammary gland","volume":"93","author":"Barcellos-Hoff","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0010","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI67313","article-title":"Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice","volume":"124","author":"Deng","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0011","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijrobp.2007.01.041","article-title":"Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth","volume":"68","author":"Tsai","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0012","doi-asserted-by":"crossref","first-page":"78653","DOI":"10.18632\/oncotarget.11823","article-title":"Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy","volume":"7","author":"Crittenden","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/731346","article-title":"Immune responses following stereotactic body radiotherapy for stage I primary lung cancer","volume":"2013","author":"Maehata","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0014","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3389\/fonc.2019.01488","article-title":"Prognosis and risk factors of radiation-induced lymphopenia in early-stage lung cancer treated with stereotactic body radiation therapy","volume":"9","author":"Zhao","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cllc.2015.07.007","article-title":"Pretreatment immune parameters predict for overall survival and toxicity in early-stage non-small-cell lung cancer patients treated with stereotactic body radiation therapy","volume":"17","author":"Shaverdian","year":"2016","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0016","article-title":"Dosimetric effect of thymus and thoracic duct on radiation-induced lymphopenia in patients with primary lung cancer who received thoracic radiation","volume":"8","author":"Zhang","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0017","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijrobp.2019.05.064","article-title":"Impact of radiation dose to the host immune system on tumor control and survival for stage III non-small cell lung cancer treated with definitive radiation therapy","volume":"105","author":"Ladbury","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0018","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jtho.2020.06.008","article-title":"Radiotherapy-related lymphopenia affects overall survival in patients with lung cancer","volume":"15","author":"Abravan","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0019","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.radonc.2019.01.032","article-title":"Pre-treatment neutrophil-lymphocyte ratio is associated with overall mortality in localized non-small cell lung cancer treated with stereotactic body radiotherapy","volume":"134","author":"Sebastian","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0020","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3109\/07357907.2012.700987","article-title":"The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas","volume":"30","author":"Balmanoukian","year":"2012","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0021","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ijrobp.2015.11.026","article-title":"Lymphocyte-sparing effect of stereotactic body radiation therapy in patients with unresectable pancreatic cancer","volume":"94","author":"Wild","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2018.07.1809","article-title":"Treatment-related lymphopenia is an independent predictor of survival in patients with lung cancer treated via stereotactic body radiation therapy","volume":"102","author":"Alonso","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0023","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijrobp.2020.01.032","article-title":"Absolute lymphocyte count predicts abscopal responses and outcomes in patients receiving combined immunotherapy and radiation therapy: Analysis of 3 phase 1\/2 trials","volume":"108","author":"Chen","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0024","unstructured":"Clinicaltrials.gov. NCT04273893: Lymphocyte Depletion and Change in Lymphocyte Functionality; Sponser University of Virginia. Accessed October 11, 2024. https:\/\/clinicaltrials.gov\/study\/NCT04273893"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0025","unstructured":"Radiation Therapy Oncology Group, Seamless Phase I\/II study of stereotactic lung radiotherapy (SBRT) for early stage, centrally located, non-small cell lung cancer (NSCLC) in medically inoperable patients. Update, 2009. https:\/\/pps4rt.com\/wp-content\/uploads\/2019\/07\/RTOG-0813.pdf"},{"issue":"suppl 3","key":"10.1016\/j.ijrobp.2026.07.012_bib0026","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ijrobp.2013.06.016","article-title":"Radiation therapy oncology group (RTOG) protocol 0915: A randomized phase 2 study comparing 2 stereotactic body radiation therapy (SBRT) schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer","volume":"87","author":"Videtic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0027","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijrobp.2004.12.060","article-title":"CT-based definition of thoracic lymph node stations: An atlas from the University of Michigan","volume":"63","author":"Chapet","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-018-0952-y","article-title":"Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: An in-silico planning study","volume":"13","author":"Basler","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0029","unstructured":"NIH\/NCI. Common, Terminology Criteria for Adverse Events (CTCAE) v5.0 | Protocol Development | CTEP, Protocol. Published (Accessed 27 November 2017)."},{"key":"10.1016\/j.ijrobp.2026.07.012_bib45","article-title":"Forecasting time-dependent radiation induced lymphocyte depletion in a clinical trial on early-stage lung cancer","author":"Nguyen","year":"2026","journal-title":"IJROBP"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110030","article-title":"The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC","volume":"190","author":"Friedes","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0031","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2011.09.049","article-title":"Maximizing tumor immunity with fractionated radiation","volume":"83","author":"Schaue","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0032","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.4049\/jimmunol.174.12.7516","article-title":"Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor","volume":"174","author":"Lugade","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0033","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1084\/jem.20052494","article-title":"Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy","volume":"203","author":"Reits","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0035","article-title":"Stereotactic body radiotherapy (SBRT) with pembrolizumab (pembro) for unresected stage I\/II non-small-cell lung cancer (NSCLC): The randomized, double-blind, phase 3 KEYNOTE-867 study","volume":"24","author":"Pircher","year":"2024","journal-title":"Immuno-Oncol Technol"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0034","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(23)01384-3","article-title":"Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: An open-label, randomised, phase 2 trial","volume":"402","author":"Chang","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0036","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2308511120","article-title":"The total mass, number, and distribution of immune cells in the human body","volume":"120","author":"Sender","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0037","article-title":"Radiation related lymphopenia for lung SBRT treatments: Measurement versus simulation","volume":"44","author":"McMullen","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0038","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.1002\/mp.17181","article-title":"Predicting radiation-induced immune suppression in lung cancer patients treated with stereotactic body radiation therapy","volume":"51","author":"Colen","year":"2024","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0039","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archinte.1997.00440290031002","article-title":"The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules","volume":"157","author":"Swensen","year":"1997","journal-title":"Arch Int Med"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0040","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1378\/chest.128.4.2490","article-title":"Clinical prediction model to characterize pulmonary nodules: Validation and added value of 18F-fluorodeoxyglucose positron emission tomography","volume":"128","author":"Herder","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0041","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/1759-7714.12635","article-title":"Image-based management of empiric lung stereotactic body radiotherapy (SBRT) without biopsy: Predictors from a 10-year single institution experience","volume":"9","author":"Hasan","year":"2018","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0042","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00408-013-9500-6","article-title":"PET\u2212CT evaluation of solitary pulmonary nodules: Correlation with maximum standardized uptake value and pathology","volume":"191","author":"Sim","year":"2013","journal-title":"Lung"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0043","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jtho.2016.03.024","article-title":"Absence of pathological proof of cancer associated with improved outcomes in early-stage lung cancer","volume":"11","author":"Shaikh","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.012_bib0044","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jtho.2018.12.035","article-title":"Survival after stereotactic body radiation therapy for clinically diagnosed or biopsy-proven early-stage NSCLC: A systematic review and meta -analysis","volume":"14","author":"IJsseldijk","year":"2019","journal-title":"J Thorac Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626040265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626040265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:29:27Z","timestamp":1792585767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626040265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":45,"alternative-id":["S0360301626040265"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.07.012","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First Measurement: Proactively Sparing the Immune System During Stereotactic Body Radiation Therapy to Early-Stage Lung Cancer\u2014A Randomized Phase II Study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}